Gsk (GLAXF) Non-cash Items (2011 - 2013)

Gsk's Non-cash Items history runs 3 years deep, the most recent figure standing at $90.7 million for Q4 2013.

• In Q4 2013, Non-cash Items rose 184.27% year-over-year to $90.7 million; the TTM figure through Dec 2013 stood at $90.7 million (up 184.27% YoY), while the FY2025 annual figure was $3.5 billion, down 44.25% from the prior year.
• Non-cash Items was $90.7 million for Q4 2013 at Gsk, up from -$107.6 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $141.4 million in Q4 2011 to a low of -$107.6 million in Q4 2012.
• Historically, Non-cash Items has averaged $41.5 million across 3 years, with a median of $90.7 million in 2013.
• The sharpest annual moves came in 2012 and 2013: Non-cash Items tumbled 176.07% in 2012, then soared 184.27% in 2013.
• A 3-year view of Non-cash Items shows it stood at $141.4 million in 2011, then tumbled by 176.07% to -$107.6 million in 2012, then surged by 184.27% to $90.7 million in 2013.
• The last three Non-cash Items figures came in at $90.7 million (Q4 2013), -$107.6 million (Q4 2012), and $141.4 million (Q4 2011), per Business Quant data.